Chemical Modification of Melphalan as a Key to Improving Treatment of Haematological Malignancies

Scientific Reports - United Kingdom
doi 10.1038/s41598-020-61436-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Aggressive Haematological Malignancies

Virchows Archiv
MedicineForensic MedicinePathologyCell BiologyMolecular Biology
2017English

Drug-Related Cardiotoxicity for the Treatment of Haematological Malignancies in Elderly

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2010English

EZH2 as a Therapeutic Target for Multiple Myeloma and Other Haematological Malignancies

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2018English

Pilot Tone as a Key to Improving the Spatial Resolution of eBPMs

2016English

Long-Term Health Related Quality of Life Following Intensive Care During Treatment for Haematological Malignancies

PLoS ONE
Multidisciplinary
2014English

Oral Melphalan as a Treatment for Platinum-Resistant Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2003English

Asbestos Exposure and Haematological Malignancies: A Danish Cohort Study

European Journal of Epidemiology
Epidemiology
2020English

Mononuclear Cell-Membrane “Fluidity”: A Study in Some Haematological Malignancies

British Journal of Cancer
Cancer ResearchOncology
1977English

Epigenetic Inactivation of the miR-124-1 in Haematological Malignancies

PLoS ONE
Multidisciplinary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy